Strep A vaccine target identified for global use
Researchers use high-throughput DNA sequencing technology to identify a potential vaccine target for Strep A.
List view / Grid view
News
Autoimmune disorders could be treated with new compounds
New research could lead to novel treatments for autoimmune disorders and sheds light on the causes of autoimmunity.
Protein discovery leads to new hyperparathyroidism drug target
A new signalling protein discovery could lead to drug-based therapies to treat hyperparathyroidism.
Molecule found to boost immune cells leads to new cancer therapy target
A study has identified a molecule which boosts immune cell function and could be used in cancer therapies.
Study reveals new opportunity for gastrointestinal drug design
A study has shown that the organisation of the gut is broken into functional compartments, improving opportunities for gastrointestinal disorder drugs and oral vaccines.
Key gene targeting could lead to treatment for Down syndrome
Researchers use stem cell-based disease models to pinpoint gene linked to impaired memory in Down syndrome.
New avenues open for the treatment of thrombosis
New study describes for the first time the structure of Ixolaris and its action on the inhibition of thrombus formation.
UK drug discovery market ‘thriving’ says new report
A new report reveals a thriving service and supply sector for the UK in addition to its research and development biotechs.
Update on the development of new novel cancer immunotherapy
The SCIB2 vaccine is to to be administered using new nanoparticle formulation in planned Phase 1/2 clinical trial.
New drug target for depression identified
Researchers find key molecule in depression and identify new therapeutic targets.
Gene editing tools market valued at $258 million in 2018
The global gene editing tools market is estimated to have accounted for more than US$258 million in terms of value in 2018.
Protein phosphorylation inhibition promotes optic nerve regeneration
New findings could be translated into the development of novel treatments for patients with optic neuropathies.
New method could speed up drug development and diminish drug trial fails
A new method of assessing the actions of medicines by matching them to their unique protein receptors could accelerate drug development.
In-depth research maps virulence factor of the influenza A virus in real time
Findings from a recent study could lead to the development of therapeutic approaches against influenza A viruses.
Tissue-damaging protein channel identified
Researchers have discovered an acid-activated protein which could stop damage to tissues as a result of stroke and other health issues.